Couts KL, Turner JA, Bemis J, et al. Actionable kinase fusions are frequent in pan-negative melanomas. SMR 2017, abstract SMR06-5.
EORTC 26951 en RTOG 9402: procarbazine-lomustine-vincristine voor anaplastisch oligodendroglioom
aug 2022 | Neuro-oncologie